NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,579,000 | -40.6% | 677,143 | -34.3% | 2.31% | -42.8% |
| Q1 2022 | $14,441,000 | -58.6% | 1,030,798 | -14.5% | 4.04% | -43.7% |
| Q4 2021 | $34,908,000 | -3.4% | 1,205,798 | 0.0% | 7.18% | +35.0% |
| Q3 2021 | $36,126,000 | +12.9% | 1,205,798 | 0.0% | 5.32% | +23.0% |
| Q2 2021 | $31,990,000 | -16.9% | 1,205,798 | -2.6% | 4.32% | -6.2% |
| Q1 2021 | $38,504,000 | -50.1% | 1,238,456 | -47.3% | 4.61% | -45.0% |
| Q4 2020 | $77,196,000 | -5.8% | 2,347,804 | -0.0% | 8.38% | -54.6% |
| Q3 2020 | $81,969,000 | – | 2,348,014 | – | 18.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
| DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
| Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
| Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
| Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
| Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
| Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
| AtonRa Partners | 24,227 | $190,424 | 0.40% |
| WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |